Drug intelligence / Profile preview

Getryl Foot Cream

Development stage: Unknown
Lead developer: Primus Remedies
Modality: Small Molecules
Administration: Topical

Overview

Getryl Foot Cream is a topical combination product developed by Primus Remedies specifically designed for diabetic foot care and the management of dry, rough, and cracked skin on the feet. The formulation contains urea (10%), dimethicone (1%), and allantoin (0.2%), along with other emollients such as liquid paraffin, glycerin, and kokum butter. Urea acts as a keratolytic agent to hydrate and exfoliate dead skin cells, dimethicone serves as a skin protectant to form an occlusive barrier against moisture loss, and allantoin promotes skin healing and soothing. Together, these ingredients work synergistically to repair cracked heels, restore skin elasticity, and prevent infections in individuals with dry skin or diabetes-related foot complications.

Brand names: Getryl Foot Cream
Other names: allantoin + dimethicone + urea

Beyond the preview

Go deeper on Getryl Foot Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Getryl Foot Cream.